Geographic · PP&E (Net)

Non Us — PP&E (Net)

Zimmer Biomet Holdings Non Us — PP&E (Net) increased by 10.8% to $875.60M in Q4 2025 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ4 2025Feb 20, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase often signals capital investment in international manufacturing capacity or infrastructure, whereas a decrease may indicate asset divestiture, high depreciation rates, or a shift toward outsourced production models.

Detailed definition

This metric reflects the net book value of tangible long-term assets, such as manufacturing facilities, distribution cen...

Peer comparison

Global medical device manufacturers often compare this metric against international revenue to assess the capital intensity and operational efficiency of their foreign segments.

Metric ID: zbh_segment_non_us_property_plant_and_equipment_net

Historical Data

2 periods
 Q4 '24Q4 '25
Value$790.50M$875.60M
QoQ Change+10.8%
YoY Change+10.8%
Range$790.50M$875.60M
Avg YoY Growth+10.8%
Median YoY Growth+10.8%

Frequently Asked Questions

What is Zimmer Biomet Holdings's non us — pp&e (net)?
Zimmer Biomet Holdings (ZBH) reported non us — pp&e (net) of $875.60M in Q4 2025.
What does non us — pp&e (net) mean?
The total value of the company's physical assets located in international regions after accounting for wear and tear.